ACTA1 and Hepatic fibrosis: As expected, TAA administration in NIKCon mice promoted the expansion of CK19+ cholangiocytes, F4/80+ macrophages/Kupffer cells, and α‐SMA+ activated HSCs, and induced liver fibrosis as revealed by Sirius Red staining (Figure 8C,D).